Jean-Marc Schiano Schiano de Colella

16PUBLICATIONS
116CO-AUTHORS
HaematologyHaematological tumoursMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 26, 2026
Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).

|Mar 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Nicolas Gower, Pierre Feugier, Jason R Westin

|Sep 24, 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.

Anaïs Schavgoulidze, Aurore Perrot, Xavier Leleu

|Sep 18, 2025
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study.

Sarah Cayla, Lionel Karlin, Jérôme Lambert

|Apr 13, 2025
Long-Term Outcomes and Management Strategies With DA-R-EPOCH in Primary Mediastinal B-Cell Lymphoma: Insights From a Single-Center Experience.

Robin Noel, Catalina Montes de Oca, Patrick Sfumato

|Jan 22, 2025
Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial.

Aurore Perrot, Cyrille Touzeau, Jerome Lambert

Pageof 3

Frequent Collaborators

5 joint publications

Salomon Manier

5 joint publications

Aurore Perrot

5 joint publications

Jill Corre

4 joint publications

Xavier Leleu